News on Medial

Related News

Clinikally amasses 1.5 Mn customers within three year of launch

EntrackrEntrackr · 1y ago
Clinikally amasses 1.5 Mn customers within three year of launch
Medial

The dermatology and wellness industry in India is experiencing rapid growth, driven by increasing awareness of skincare, modern lifestyles and the influence of social media. With the vast array of products available in the market, professional guidance and personalized consultations are becoming essential to determine what works best for individual skin and hair needs. To address this problem, Clinikally, a digital healthcare platform, is transforming dermatology in India with its innovative telehealth solution that connects patients with leading dermatologists. Founded in 2022 by Arjun Soin, Clinikally provides skin, hair, and health supplement products, featuring verticalized online pharmacy with over 5,000 SKUs across 250 brands. The company leverages advanced AI systems to deliver personalized product recommendations by analysing user purchases, prescription histories, and demographic details. The company is backed by the likes of Y-Combinator, TribeCapital, Arash Ferdowsi (Dropbox founder), and Kunal Shah. Clinikally claims to have served over 1.5 million customers, reaching more than 500 cities and 18,000+ pin codes pan India. Notably, the split between skin and hair is 60% and 40% respectively. For the growth prospects, Clinially plans to launch its Android and iPhone apps and expand into the nutrition and weight-loss markets, and establish warehouses in major urban hubs across Tier-1 cities. Clinikally is also preparing to pilot omnichannel-user engagement models in select cities to redefine how Indians approach skin and hair care, offering expert dermatological solutions.

Y Combinator-backed CureSkin raises $20 Mn led by Healthquad

EntrackrEntrackr · 1y ago
Y Combinator-backed CureSkin raises $20 Mn led by Healthquad
Medial

CureSkin, a beauty and personal care brand, has raised $20 million in a Series B funding round led by Healthquad. The round also saw participation from JSW Ventures, Khosla Ventures, and Sharrp Ventures. The company has raised $26 million to date including a $5 million Series A in March 2022. It was a part of Y Combinator Summer Batch in 2017. The new funds will be utilised to enhance AI capabilities further and broaden its range of solution offerings, CureSkin said in a press release. Founded in 2017 by Guna Kakulapati, Ramakrishna Rajanna and Dr Charu Sharma, CureSkin uses tech to analyze users’ skin conditions such as acne, hyperpigmentation, and hair loss with high accuracy and recommends a personalized treatment kit and care plan. The Bengaluru-based company has helped over 1.5 million users and uses more than 10 million skin pixels to determine up to 2,000 facial attributes to understand the concerns of users. Cureskin also said that about 80% of the company’s existing users are in tier II and III cities. Cureskin registered Rs 35.46 crore in revenue from operations in FY23 against Rs 2.57 crore in total revenue in FY22, according to startup data intelligence platform TheKredible. During the period, its losses also jumped to Rs 28 crore from Rs 2.57 crore. As of Series A round, the company’s chief executive Kakulapati had 28% stake in the firm followed by Rajanna who held 12% of the company. Among the investors, JSW Ventures had 10.4% stake whereas Khosla Ventures acquired 8% in the firm during the last round. Check TheKredible for more details. Cureskin competes with a clutch of companies including Clinikally, which was also a part of Y Combinator’s accelerator program and raised $2.6 million in September last year.

Download the medial app to read full posts, comements and news.